Market News AIOpen the app

DZ Bank increased its price target for Fresenius Medical Care from 46 EUR to 50 EUR, keeping a 'Buy' rating.

OpinionRead the original at finanzen.ch
Neutral

Fresenius Medical Care received a higher bank target after the bank lowered its penalty for uncertainty. The slightly better-than-expected third quarter is countered by lower 2027 estimates, leaving the company's outlook unchanged.

FMS · Fresenius Medical Care

AI read · Neutral

The AI's read

The higher target came from a smaller penalty for uncertainty tied to the US election and the government's position on kidney disease treatment. It did not come from stronger company results. The third-quarter result was slightly better than expected, but the bank lowered its 2027 estimates. These signs point in different directions, so they do not change how we read the company.

Get alerts for FMS

Follow Fresenius Medical Care (FMS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for FMS
Free on the App Store and Google Play, or on the web.